Your request to link to rcsb for [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial

---

• 1JM6: pyruvate dehydrogenase kinase, isozyme 2, containing adp (10.1074/JBC.M104285200 )
• 2BTZ: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 2BU2: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 2BU5: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 2BU6: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 2BU7: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 2BU8: crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands (10.1021/BI051402S )
• 3CRK: crystal structure of the pdhk2-l2 complex. (10.1074/JBC.M800311200 )
• 3CRL: crystal structure of the pdhk2-l2 complex. (10.1074/JBC.M800311200 )
• 4MP2: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor pa1 (10.1074/JBC.M113.533885 )
• 4MP7: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor pa7 (10.1074/JBC.M113.533885 )
• 4MPC: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps2 (10.1074/JBC.M113.533885 )
• 4MPE: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps8 (10.1074/JBC.M113.533885 )
• 4MPN: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps10 (10.1074/JBC.M113.533885 )
• 4V25: ver-246608, a novel pan-isoform atp competitive inhibitor of pyruvate dehydrogenase kinase, disrupts warburg metabolism and induces context- dependent cytostasis in cancer cells (10.18632/ONCOTARGET.2656 )
• 4V26: ver-246608, a novel pan-isoform atp competitive inhibitor of pyruvate dehydrogenase kinase, disrupts warburg metabolism and induces context- dependent cytostasis in cancer cells (10.18632/ONCOTARGET.2656 )
• 5J6A: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps46 (10.1021/ACS.JMEDCHEM.6B01540 )
• 5J71: crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor ps35 (10.1021/ACS.JMEDCHEM.6B01540 )
• 5M4K: application of off-rate screening in the identification of novel pan- isoform inhibitors of pyruvate dehydrogenase kinase (10.1021/ACS.JMEDCHEM.6B01478 )
• 5M4M: application of off-rate screening in the identification of novel pan- isoform inhibitors of pyruvate dehydrogenase kinase (10.1021/ACS.JMEDCHEM.6B01478 )
• 5M4N: application of off-rate screening in the identification of novel pan- isoform inhibitors of pyruvate dehydrogenase kinase (10.1021/ACS.JMEDCHEM.6B01478 )
• 5M4P: application of off-rate screening in the identification of novel pan- isoform inhibitors of pyruvate dehydrogenase kinase (10.1021/ACS.JMEDCHEM.6B01478 )
• 6LIL: crystal structure of human pdk2 complexed with an allosteric inhibitor compound 8c (10.1016/J.BBRC.2020.04.102 )
• 6LIN: crystal structure of human pdk2 complexed with gm10030 (10.1016/J.BBRC.2020.04.102 )
• 6LIO: crystal structure of human pdk2 complexed with gm67520 (10.1016/J.BBRC.2020.04.102 )
• 7EA0: crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 1 (10.1016/J.BMC.2021.116283 )
• 7EAS: crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 2 (10.1016/J.BMC.2021.116283 )
• 7EBH: crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 13 (10.1016/J.BMC.2021.116283 )